On October 19th, 2021 PERMIT WP6 hosted a virtual workshop on study designs of clinical trials (CTs) for personalised medicine (PM) with 22 stakeholders from the PM research ecosystem. The workshop aimed to develop a single definition of CT for PM, valid for all participants and to identify the specific characteristics of a CT for PM on which future recommendations should focus. In addition, the workshop sought to identify the study designs for assessing a PM vs. non-PM strategy and its attributes. Focus groups will be organized with experts to further discuss some challenges raised during the workshop. Insights and comments of all participants will be used to develop a more advanced version of the recommendations.
🗣️On the age#patienttient auton#HTA #HTA, acces#PMo #PM, in-depth discussion w/ participants The workshop will in#PERMITprojectoject's work to establish recommendation#PersonalisedMedicineicine methods, sci.excellence, validity, robustness, & mpermit-eu.orgRIGbW https://t.co/EAIesHPuRn
🔚Thats a wrap! A fruitful day f#PERMITprojectect: 🧠Brainstorming the ethical issu#PersonalisedMedicinedicine with colleaguesECRIN_ERICN_ERIC & TMF-VE, and clinician, ethi#HTA, #HTA #patientatient representatives Learn more about PERMIT & the role of EPeu-patient.eu/Projects/ongoi…TfHNgM https://t.co/HqkyWgbZn8
Attention personalised medicine community and members of the #PERMITproject. The most recent member of the ICPerMed family is planning two information sessions (EN & FR) in December. Don't miss this opportunity to learn about how this project will develop new collaborations. twitter.com/EU_AfricaPerMe…